These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 9118046

  • 1. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
    Broun ER, Nichols CR, Gize G, Cornetta K, Hromas RA, Schacht B, Einhorn LH.
    Cancer; 1997 Apr 15; 79(8):1605-10. PubMed ID: 9118046
    [Abstract] [Full Text] [Related]

  • 2. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER, Nichols CR, Turns M, Williams SD, Loehrer PJ, Roth BJ, Lazarus HM, Einhorn LH.
    Cancer; 1994 Mar 15; 73(6):1716-20. PubMed ID: 7512438
    [Abstract] [Full Text] [Related]

  • 3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M, Simon SD, de Góes GM.
    J Urol; 1985 Jul 15; 134(1):65-9. PubMed ID: 2409300
    [Abstract] [Full Text] [Related]

  • 4. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ, Mazumdar M, Gulati SC, Bajorin DF, Lyn P, Vlamis V, Bosl GJ.
    J Natl Cancer Inst; 1993 Nov 17; 85(22):1828-35. PubMed ID: 7693955
    [Abstract] [Full Text] [Related]

  • 6. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M.
    J Clin Oncol; 1996 Oct 17; 14(10):2631-7. PubMed ID: 8874321
    [Abstract] [Full Text] [Related]

  • 7. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D.
    J Clin Oncol; 1994 Jun 17; 12(6):1223-31. PubMed ID: 7911158
    [Abstract] [Full Text] [Related]

  • 8. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
    Lotz JP, André T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J, Izrael V.
    Cancer; 1995 Feb 01; 75(3):874-85. PubMed ID: 7828139
    [Abstract] [Full Text] [Related]

  • 9. [The chemotherapy of nonseminomatous testicular tumors].
    Tiuliandin SA, Bulanov AA, Titov DA, Sokolov AV, Sholokhov VN, Garin AM.
    Urol Nefrol (Mosk); 1996 Feb 01; (2):26-9. PubMed ID: 8677548
    [Abstract] [Full Text] [Related]

  • 10. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
    Motzer RJ, Gulati SC, Tong WP, Menendez-Botet C, Lyn P, Mazumdar M, Vlamis V, Lin S, Bosl GJ.
    Cancer Res; 1993 Aug 15; 53(16):3730-5. PubMed ID: 8393380
    [Abstract] [Full Text] [Related]

  • 11. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
    Saiki S, Meguro N, Maeda O, Kinouchi T, Kuroda M, Usami M, Kotake T, Miki T.
    Hinyokika Kiyo; 1999 Nov 15; 45(11):777-81. PubMed ID: 10637743
    [Abstract] [Full Text] [Related]

  • 12. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A, Hayward J, Kirkwood A, McCarthy K, Hewitt M, Morland B, Daw S.
    Br J Haematol; 2014 May 15; 165(4):534-44. PubMed ID: 24754633
    [Abstract] [Full Text] [Related]

  • 13. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
    Tanji S, Obara W, Sugimura J, Ohmori S, Matsushita Y, Tokunaga H, Konda R, Fujioka T, Murai K, Ishida Y.
    Hinyokika Kiyo; 2004 Feb 15; 50(2):77-80. PubMed ID: 15101160
    [Abstract] [Full Text] [Related]

  • 14. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K, Prow DM, Do KA, Wang X, Finn L, Kim J, Daliani D, Papandreou CN, Tu SM, Millikan RE, Pagliaro LC, Logothetis CJ, Amato RJ.
    Br J Cancer; 2002 May 20; 86(10):1555-60. PubMed ID: 12085204
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
    Broun ER, Nichols CR, Kneebone P, Williams SD, Loehrer PJ, Einhorn LH, Tricot GJ.
    Ann Intern Med; 1992 Jul 15; 117(2):124-8. PubMed ID: 1318648
    [Abstract] [Full Text] [Related]

  • 16. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB, Antoniolli SZ, Maffei N, Beltrami P, Bassetto MA, Curti P.
    Arch Ital Urol Androl; 2002 Jun 15; 74(2):81-5. PubMed ID: 12161942
    [Abstract] [Full Text] [Related]

  • 17. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
    Nieto Y, Tu SM, Bassett R, Jones RB, Gulbis AM, Tannir N, Kingham A, Ledesma C, Margolin K, Holmberg L, Champlin R, Pagliaro L.
    Ann Oncol; 2015 Oct 15; 26(10):2125-32. PubMed ID: 26199392
    [Abstract] [Full Text] [Related]

  • 18. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A, Biron P, Philip I, Blay JY, Droz JP.
    Bull Cancer; 1999 Apr 15; 86(4):391-9. PubMed ID: 10341344
    [Abstract] [Full Text] [Related]

  • 19. Salvage therapy in recurrent testicular cancer.
    Saxman S.
    Semin Oncol; 1992 Apr 15; 19(2):143-7. PubMed ID: 1372756
    [Abstract] [Full Text] [Related]

  • 20. Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
    Ayash LJ, Clarke M, Silver SM, Braun T, Uberti J, Ratanatharathorn V, Reynolds C, Ferrara J, Broun ER, Adams PT.
    Bone Marrow Transplant; 2001 May 15; 27(9):939-47. PubMed ID: 11436104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.